What We're Reading: Page 75
Industry reads hand-picked by our editors
Nov 06, 2023
-
C&EN
Is this a golden age of small-molecule drug discovery?
-
Financial Times
Novo Nordisk warns EU that new rules will push it to expand faster in US
-
FirstWord Pharma
US watchdog calls for more transparency in fair access to drugs
-
PharmaVoice
The thorniest questions facing pharma, according to a leading bioethicist
Nov 03, 2023
Nov 02, 2023
-
Reuters
Moderna tempers 2023 COVID vaccine sales forecast
-
San Francisco Business Times
Biotech startup Gate Biosciences taps new way to attack diseases
-
Fierce Biotech
At ESMO, oncologists reflect on the global dominance of GLP-1s
Nov 01, 2023
Oct 31, 2023
Oct 30, 2023
Oct 27, 2023
-
Reuters
AbbVie raises profit forecast after Humira, newer drugs drive results beat
-
Fierce Biotech
After massive $401M raise, ElevateBio lets 13% of staff go
-
FirstWord Pharma
US approves Santhera’s Agamree for Duchenne muscular dystrophy
-
Stat
Prime Medicine says its gene editing passes test in monkeys
Previous
